📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting. (2021)

First Author: Meade A

Attributed to: Design of Trials, Meta-analyses and observational studies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cct.2021.106481

PubMed Identifier: 34538401

Publication URI: http://europepmc.org/abstract/MED/34538401

Type: Journal Article/Review

Volume: 108

Parent Publication: Contemporary clinical trials

ISSN: 1551-7144